Возбудитель

Cryptocline cyclaminis

Cryptocline cyclaminis

Description

Cryptocline cyclaminis is a specialized fungal pathogen classified within the kingdom Fungi. It is primarily recognized as the causal agent of leaf spot disease in cyclamen plants. As a plant pathogen, it specifically targets the foliage, causing significant damage that affects the health and aesthetic value of ornamental cyclamen grown in nurseries and indoor environments.

The disease manifests as distinct lesions on the leaves, which typically begin as small, pale spots before expanding into brown or necrotic areas. These spots are often surrounded by a chlorotic halo. As the infection progresses, the leaves become weak, lose their vibrant color, and eventually drop off, severely impacting the plant's overall photosynthesis and growth potential.

The life cycle of the pathogen is driven by the production of asexual spores (conidia). These spores are highly mobile and are spread primarily through water splashes, contaminated hands, or farming tools. Once the spores land on a susceptible leaf surface, they germinate and penetrate the tissue, eventually establishing a network of mycelium that continues to fuel the disease cycle.

Environmental conditions play a crucial role in the epidemiology of Cryptocline cyclaminis. It thrives in high humidity environments and cool to moderate temperatures, typically ranging from 18°C to 22°C. Poor air circulation and overcrowding in greenhouses create a conducive environment for rapid sporulation and disease transmission between healthy and infected plants.

Integrated management is essential for controlling this pathogen. Growers should prioritize cultural practices such as spacing plants to improve airflow, using drip irrigation to keep foliage dry, and promptly disposing of infected leaf debris. In severe outbreaks, applying targeted fungicides is necessary to manage the population of the fungus and protect the remaining crop from secondary infection.

Content graph

Вызывает болезни · 1

Community

Discussion

No discussions yet — be the first.